FDA Inspection
OSRX Inc.OSRX Inc. – FDA Inspection, Apr 25, 2019
Record Details
This FDA Inspection record concerns OSRX Inc., with an inspection on April 25, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · dd0491e1-78cc-4e97-8abb-8c123ea117df
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1087576
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
1- FDCA 501(a)(2)(A)Inadequate filter, final product sterilization
Full citation text and observation details available on the Dashboard.
Other FDA inspections of OSRX Inc.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| November 14, 2025 | Not classified | Seattle District Office | Drug Quality Assurance |
| October 25, 2024 | OAI | Seattle District Office | Drug Quality Assurance |
| September 23, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for OSRX Inc.
- FDA Inspection 1283268 - 2025-11-14
- FDA Inspection 1246254 - 2024-10-25
- FDA Inspection 1154392 - 2021-09-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.